L3P40-50โa new lung-tumor-associated 40-
โ
Fred-Thomas Brezicka; Sante Olling
๐
Article
๐
1994
๐
John Wiley and Sons
๐
French
โ 515 KB
A monoclonal antibody (MAb), designated L3, was raised against a human-lung-adenocarcinoma-derived cell line, A549. lmmunohistological studies showed reactivity of MAb L3 with 70 to 90% of lung tumors representing the 4 major histotypes. Strongest reactivity was seen with squamous-cell cancer and a